What Can ICER Learn from Big Tech Companies?
The Institute for Clinical and Economic Review's (ICER) reputation has seen significant growth, but the author of a recent article [...]
Article: ICER’s Judgements ‘Anchored by Cost-Effectiveness’
The authors of a recent article suggest that Institute for Clinical and Economic Review (ICER) council members' judgements are ultimately [...]
ICER Releases Draft Report on NASH Drug
The Institute for Clinical and Economic Review (ICER) released a draft evidence report on Intercept Pharmaceuticals' obeticholic acid for the [...]
ICER Indefinitely Postpones Public Meetings, Expands Assessment Timelines
In response to the COVID-19 pandemic, the Institute for Clinical and Economic Review (ICER) announced it would indefinitely postpone several [...]
ICER Posts Reports Outlining Two Planned Reviews
The Institute for Clinical and Economic Review (ICER) on Friday, March 13, posted two new draft scoping documents outlining planned [...]
Webinar to Outline Key Takeaways of ICER’s Updated Value Framework
Boston Healthcare Associates is slated to highlight the Institute for Clinical and Economic Review's (ICER) updated value assessment framework in [...]
ICER Launches New Suite of Interactive Tools
The Institute for Clinical and Economic Review (ICER) recently announced a new set of interactive tools that could serve as [...]
ICER Releases Final Report on Acute Treatments for Migraine
The Institute for Clinical and Economic Review (ICER) on Tuesday, Feb. 25, released its final report on three acute treatments [...]
ICER Announces RWE Partnership with Aetion
The Institute for Clinical and Economic Review (ICER) is partnering with Aetion to "generate decision-grade real-world evidence," the drug pricing [...]
Pearson: Program to Bolster Patient Involvement in Review Process
The Institute for Clinical and Economic Review's (ICER) new Patient Engagement Program is a big leap forward for the drug [...]
Tufts’ Cohen Highlights ICER’s Third Value Assessment Framework
Tufts Medical Center's Joshua Cohen, deputy director of the Center for the Evaluation of Value and Risk in Health, in [...]
Analysis Looks at ICER’s FDA Outreach Plan
A recent analysis by the Pink Sheet spotlights a new initiative by the Institute for Clinical and Economic Review (ICER) [...]
ICER Plans Review of Bladder Cancer Treatment
The Institute for Clinical and Economic Review (ICER) announced plans to review FKD Therapies Oy and Ferring Pharmaceuticals' Instiladrin for [...]
ICER Releases Draft Report on Cystic Fibrosis Therapies
The Institute for Clinical and Economic Review (ICER) on Thursday, Feb. 20, released a draft evidence report on treatments for [...]
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic Platform, hēRo3
Policy Analysis Inc. (PAI), a Boston-based health-economics consultancy, on Wednesday, Feb. 19, announced that it had signed a multi-year deal [...]
ICER’s Whitrap: Not All Investors See Only Dollar Signs
David Whitrap, Institute for Clinical and Economic Review vice president of communications and outreach, in a recent post says some [...]
Analysis Suggests ICER’s QALY Approach Violates ADA
A new analysis by the Pioneer Institute, "The Legality of QALY under the ADA," suggests that the Institute for Clinical [...]
Report: ICER to Assess RWE on Accelerated Approvals
The Institute for Clinical and Economic Review (ICER) will incorporate real-world evidence into future updates of already-reviewed according to a [...]
ICER Finalizes Updates to Value Assessment Framework
The Institute for Clinical and Economic Review (ICER) on Jan. 31 published an updated version of its value assessment framework [...]
ICER Hosts Meeting on Migraine Treatments
The Institute for Clinical and Economic Review (ICER) hosted a public meeting last week to discuss new treatments for migraines. [...]
Pearson: Patient Engagement is Key to Fixing ‘Broken’ System
The key first step to fixing the "broken" U.S. health care system is to overhaul how organizations engage with patients, [...]
ICER Outlines Planned Review of Hemophilia A Treatments
The Institute for Clinical and Economic Review (ICER) released a draft scoping document outlining its planned review of two treatments [...]
ICER Posts Draft Report on Sickle Cell Disease Therapies
The Institute for Clinical and Economic Review (ICER) on Thursday, Jan. 23, released a draft evidence report assessing treatments for [...]
ICER Releases Final Report on JAK Inhibitors for RA
The Institute for Clinical and Economic Review (ICER) on Thursday, Jan. 9, released its final report on JAK inhibitors for [...]
Researchers Find ICER Makes ‘Modest’ Revisions Based on Comments
Tufts Medical Center researchers in a recent article published in Value in Health found that the Institute for Clinical and [...]
